Oxford starts human testing of Nipah virus vaccine

Oxford starts human testing of Nipah virus vaccine

Publication date: Apr 03, 2026

Its fatality rate is estimated at 40% to 75%, according to the World Health Organization.

Concepts Keywords
Astrazeneca Brain
Bangladesh Early
Bat India
Killer Kerala
Vaccines Led
Nipah
Outbreaks
Oxford
Started
Swelling
Testing
Trial
Vaccine
Virus
Years

Semantics

Type Source Name
disease MESH COVID-19
disease MESH brain swelling
disease MESH headache cough
disease MESH fever
disease MESH infection
disease MESH Infectious Diseases
disease MESH Allergy
disease MESH emerging infectious diseases

Leave a Comment

Your email address will not be published. Required fields are marked *